Search Within

Paola Ghione

Formats
  1. Meeting Abstract (58)
  2. Journal Article (26)
  3. Editorial (3)
  4. Research Letter (3)
  5. Review (2)
Groups
  1. Sloan Kettering Institute Postdocs (92)
  2. Department of Medicine (78)
  3. Hematologic Malignancies, Division of (78)
  4. Center for Hematologic Malignancies (76)
  5. Lymphoma (75)
  6. Population Sciences Research Program (59)

More Groups

People
  1. Steven Horwitz (59)
  2. Alison Moskowitz (50)
  3. Maria Palomba (45)
  4. Ahmet Dogan (37)
  5. Ariela Noy (37)
  6. Andrew Zelenetz (35)

More People

Years
  1. 2025 (9)
  2. 2024 (29)
  3. 2023 (23)
  4. 2022 (2)
  5. 2021 (6)
  6. 2020 (14)

More Years

Publications
  1. Blood (45)
  2. Hematological Oncology (8)
  3. Journal of Clinical Oncology (6)
  4. Haematologica (5)
  5. Blood Advances (4)
  6. Leukemia and Lymphoma (3)

More Publications

Publishers
  1. American Society of Hematology (49)
  2. Wiley Blackwell (12)
  3. American Society of Clinical Oncology (6)
  4. Ferrata Storti Foundation (5)
  5. Taylor & Francis Group (4)
  6. Elsevier Inc. (3)

More Publishers

Results (92)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antigen-specific t-cell repertoire responses following COVID-19 vaccination are intact in majority of patients with B-cell lymphoid malignancies on active therapy
    Meeting Abstract

    Goel, S.; Griffiths, E. A.; Segal, B.; Nemeth, M.; Cortese, M. J.; Hernandez-Ilizaliturri, F. J.; Banbury, B.; Schumacher, E.; Torka, P.; Ghione, P.
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Meeting Abstract

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; Horwitz, S. M.; Geller, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Cumulative incidence of myeloid neoplasms in patients with nodal T-follicular helper cell lymphoma
    Meeting Abstract

    Stuver, R.; Ganesan, N.; Dogan, A.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Lewis, N.; Moskowitz, A.; Shah, G. L.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Infectious complications in patients with relapsed or refractory (R/R) Non-Hodgkin's lymphoma (NHL) treated with the anti-CD20xCD3 bispecific antibody (BsAb) mosunetuzumab
    Meeting Abstract

    Shahid, Z.; Okwali, M.; Joseph, A.; Seo, S. K.; Lue, J. K.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Potent CD8+T-cell proliferation and effector differentiation following subcutaneous (SC) mosunetuzumab administration in patients with untreated, high tumor-burden follicular lymphoma (FL)
    Meeting Abstract

    Falchi, L.; Lin, Y. H.; Melendez, L.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Kumar, A.; Palomba, M. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparative effectiveness of axicabtagene ciloleucel vs historical standard-of-care in patients with relapsed or refractory follicular lymphoma: An analysis of CIBMTR and SCHOLAR-5 data
    Meeting Abstract

    Kambhampati, S.; Wang, H. L.; Yan, J.; Herrera, A. F.; Frank, M. J.; Popplewell, L. L.; Ahmed, N.; Lin, Y.; Locke, F. L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save